Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata

British Journal of Dermatology

Volumn 163, Issue 3, 2010, Pages 523-531

  Telford, G ^a   Brown, A P ^a   Seabra, R A M ^a   Horobin, A J ^a   Rich, A ^b   English, J S C ^b   Pritchard, D I ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

chymotrypsin; debridement; eschar; maggot; recombinant; wound

Indexed keywords

DERMATOLOGICAL AGENT; RECOMBINANT CHYMOTRYPSIN I; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DNA SEQUENCE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ESCHAR; EX VIVO STUDY; FLY; HUMAN; HUMAN TISSUE; LEG ULCER; LUCILIA SERICATA; MOLECULAR CLONING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE HOMOLOGY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; WOUND;

ANIMALS; BLOTTING, WESTERN; CATTLE; CHYMOTRYPSIN; DIPTERA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LARVA; PROTEOMICS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VARICOSE ULCER; WOUND HEALING;

EID: 77955894127     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09854.x     Document Type: Article

References (21)

1. Leaper DJ, Harding KJ (eds). Wounds: Biology and Management. Oxford:Oxford University Press, 1988.
2. Lewis R, Whiting P, ter Riet G et al. A rapid and systematic review of the clinical effectiveness and cost effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess 2001 5:1 131.
3. Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Continence Nurs 2008 35:273 280.
4. Steed DL. Debridement. Am J Surg 2004 187:S71 4.
5. Sherman RA, Hall MJR, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000 45:55 81.
6. Church JC. Larval intervention in the chronic wound. Eur Wound Management Assoc J 2001 1:10 13.
7. Chambers L, Woodrow S, Brown AP et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003 148:14 23.
8. Horobin AJ, Shakesheff KM, Woodrow S et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003 148:923 933.
9. Horobin AJ, Shakesheff KM, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005 13:422 433.
10. Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata secretions. J Invest Dermatol 2006 126:1410 1418.
11. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 1976 72:248 254.
12. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227:680 685.
13. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979 76:4350 4354.
14. Schagger H, Vonjagow G. Tricine sodium dodecyl-sulfate polyacrylamide-gel electrophoresis for the separation of proteins in the range from 1-kDa to 100-kDa. Anal Biochem 1987 166:368 379.
15. Herrero S, Combes EM, van Oers MM et al. Identification and recombinant expression of a novel chymotrypsin from Spodotera exigua. Insect Biochem Mol Biol 2005 35:1073 1082.
16. Weingarten M. State of the art treatment of chronic venous disease. Clin Infect Dis 2001 32:949 954.
17. Christensen C, Yeager AA. Case study: a unique approach to compliance in a patient with venous ulcers. J Vasc Nurs 2001 19:52 4.
18. Mulder G, Jones R, Cederholm-Williams S et al. Fibrin cuff lysis in chronic venous ulcers treated with a hydrocolloid dressing. Int J Dermatol 2007 32:304 306.
19. Jaklič D, Lapanje A, Zupančič K et al. Selective antimicrobial activity of maggots against pathogenic bacteria. J Med Microbiol 2008 57:617 625.
20. Daeschlein G, Mumcuoglu KY, Assadian O et al. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol Physiol 2007 20:112 115.
21. Bexfield A, Nigam Y, Thomas S, Ratcliffe NA. Detection and partial characterisation of two antibacterial factors from the excretionssecretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus. Microbes Infect 2004 6:1297 1304.